本頁面由Tiger Trade Technology Pte. Ltd.提供服務

再生元製藥公司

781.49
-11.7700-1.48%
盤後781.490.00000.00%19:36 EDT
成交量:44.40萬
成交額:3.48億
市值:804.58億
市盈率:19.33
高:800.22
開:800.00
低:780.81
收:793.26
52周最高:859.34
52周最低:541.00
股本:1.03億
流通股本:9,888.36萬
量比:0.80
換手率:0.45%
股息:3.64
股息率:0.47%
每股收益(TTM):40.43
每股收益(LYR):41.48
淨資產收益率:14.04%
總資產收益率:6.53%
市淨率:2.54
市盈率(LYR):18.84

資料載入中...

2020/08/12

重要事件披露

8-K - Current report
2020/08/07

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/05

重要事件披露

8-K - Current report
2020/07/07

重要事件披露

8-K - Current report
2020/06/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/16

重要事件披露

8-K - Current report
2020/06/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/05/29

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/29

重要事件披露

8-K - Current report
2020/05/26

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/05/26

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/05/05

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/05/05

重要事件披露

Current report, items 2.02 and 9.01
2020/04/07

重要事件披露

Current report, item 1.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]